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INTRODUCTION 
Pain is defined as an unpleasant sensory and emotional experience which 
may be associated with actual or potential tissue damage[1]. Surgical trauma 
induces hyperalgesia which could lead to chronic pain in the post operative 
period when left unattended . 
Post operative pain could be attributed to inflammation resulting from 
tissue trauma due to the surgical incision , tissue injury due to cauterization or 
direct nerve injury as a result of  nerve transection, stretching or compression. 
Pro-inflammatory mediators released as a result of tissue injury such as 
prostaglandins, interleukins, cytokines and neurotrophins contribute to 
nociceptor sensitization. Also, a decrease in tissue pH and oxygen tension, and 
increased lactate concentration which may be persistent at the  surgical site for 
several days play an important role in  peripheral sensitization and 
spontaneous pain behavior following an incision [2]. 
Inadequately treated post operative pain may have various systemic 
implications on the patient such as tachycardia, hypertension, increased blood 
glucose, delayed wound healing and anxiety. Anxiety leads to a surge of 
catecholamines due to the stress response leading to tachycardia, hypertension 
and hemodynamic instability. Therefore the relationship between anxiety and 
pain is well established. 
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In fact, pain has been described as one of the causes for delayed 
discharge from the hospital after ambulatory surgery along with drowsiness 
and nausea/vomiting.[3] 
 Depression, psychological stress and late recovery are related to chronic 
post-surgical pain, which may occur even after a minor surgery. Hence, 
adequate post-operative pain relief must be an integral part of administration 
of anaesthesia. Major goal of postoperative pain management is to minimize 
the dose of medication, to lessen the side effects and provide adequate 
analgesia. This can be achieved by multimodal approach to pain management 
 Drugs such as IV paracetamol, IV diclofenac, COX 2 inhibitors and 
opioids do not necessarily meet all the requirements of post-surgical 
patients.[4] Opioids were used but their associated complications have led to 
the restriction in usage. 
Multimodal analgesia therefore takes into account the exact mechanisms, 
new pharmaceutical products and other routes and modes of delivery of 
analgesics.  
Based on the knowledge available regarding the management of post 
operative pain, this study was designed to compare the pre-emptive analgesic 
efficacy of oral gabapentin versus oral pregabalin in patients undergoing lower 
limb orthopaedic surgeries under spinal anaesthesia. 
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AIM OF THE STUDY 
 
To evaluate and compare the preemptive analgesic efficacy of oral 
gabapentin vs oral pregabalin for postoperative analgesia in patients 
undergoing elective orthopaedic lower limb surgeries under spinal anaesthesia 
and to assess the incidence of  adverse effects of gabapentin and pregabalin 
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PATHOPHYSIOLOGY OF NOCICEPTION 
 Definition of pain 
The international Association for the study of pain (IASP) defines pain 
as“an unpleasant sensory and emotional experience associated with actual or 
potential tissue damage or described in terms of such damage”[5] 
 
Physiology of pain[6] 
The neural response to painful stimuli is defined as nociception. 
The physiological processes involved in nociception are 
• Transduction 
• Transmission 
• Perception 
• Modulation 
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Picture demonstrating physiological process of nociception 
 
TRANSDUCTION: 
Tissue injury generates noxious stimuli which gets converted into 
electrical signals by a process known as transduction. This process occurs in 
nociceptors. Free nerve endings of unmyelinated C fibres and myelinated Aδ 
fibres act as nociceptors . 
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There are different types of nociceptors: 
• mechanoreceptors : They respond to pinch and pinprick. 
• Silent nociceptors : Respond only during inflammation 
• Polymodal nociceptors: respond to pain temperature and pressure. 
Nociceptors do not have the property to adapt to noxious stimuli which 
induces continued excitation leading to reduced threshold of nociceptors and is 
termed as sensitization of nociceptors. 
Primary afferent neurons of nociception which  are of pseudo unipolar 
variety have their cell bodies in dorsal root ganglia, with a peripheral terminal 
which ends as nociceptors and a central terminal which synapses with second 
order neurons in the dorsal horn of spinal cord.  
The noxious stimuli can be chemical, mechanical or thermal. The 
stimulation leads to release of prostaglandin, bradykinin, serotonin, substance 
P, Potassium, and histamine from damaged tissues. These neurotransmitters 
released peripherally leads to sensitization of nociceptors to painful stimulus. 
Exchange of sodium and potassium ions at the cell membranes results in 
action potential and thereby generating  pain impulse. 
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TRANSMISSION: 
Transmission of pain impulse occurs from periphery to the spinal cord 
and then to thalamus and finally to the cerebral cortex.  
 Primary afferent fibres are the first order neurons which conduct pain 
impulse from nociceptors to dorsal horn neurons and are of two types: C fibres 
and Aδ fibres. 
C fibres : They are unmyelinated with small diameter with a slow conduction 
velocity of 0.5–2m/s. They conduct more than one type of noxious stimuli and 
hence called as polymodal nociceptors. The C fibres conduct a diffuse, dull, 
slow onset pain known as second pain and they terminate on neurons of 
lamina I and II in dorsal horn of spinal cord. 
Aδ fibres : They are myelinated with large diameter with a high conduction 
velocity of  2–20m/s. They respond to high intensity mechanical stimuli and 
hence called high threshold mechanoreceptors. They conduct a sharp, well 
localised, fast pain called as first pain. These fibres terminate on the neurons 
of lamina I and V in the dorsal horn of spinal cord. There is a synaptic cleft 
between the first order and second order neurons in the dorsal horn of spinal 
cord and the transmission of pain impulse across this cleft is mediated by 
release of excitatory neurotransmitters such as glutamate, substance P, 
calcitonin gene related peptide, adenosine triphosphate, bradykinin and nitrous 
oxide. Impulses from the first order neurons to the thalamus are conducted by 
the second order neurons. Second order neurons are of two types: 
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• Nociceptive specific(NS) and 
• Wide dynamic range neurons(WDR)  
NS neurons respond only to painful stimuli whereas WDR neurons 
respond to both noxious and non noxious input from Aβ, Aδ, and C fibres. 
Most of the second order neurons cross the midline to opposite side and 
ascend as spinothalamic tract(STT) to relay in thalamus. STT also sends fibres 
to reticular formation, nucleus raphe magnus and periaqueductal gray. STT 
can be divided into lateral and medial tracts. The lateral STT(neo spino 
thalamic) terminates in ventral posterolateral nucleus of thalamus transmitting 
pain and temperature and is responsible for emotional perception of pain. 
Third order neurons are involved in transmitting the pain impulse from 
thalamus to somatosensory areas I & II in the postcentral gyrus and superior 
wall of the sylvian fissure in the cerebral cortex. 
 
PERCEPTION: 
The process by which pain produces conscious multidimensional 
experience is known as perception. Areas of cortex involved in pain 
perception include, 
The reticular system – mediates motor response to pain. 
Somatosensory cortex- Responsible for perceiving and interpreting the 
sensation and assessing the intensity, type and location of sensation and is 
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involved in comparing the sensation with past experiences and is responsible 
for memory of sensation. 
Limbic system-Responsible for emotional and behavioural responses to 
pain.[7] 
 
MODULATION: 
Modulation is the process by which pain impulses produced are either 
inhibited or facilitated. It occurs peripherally in nociceptors and also in spinal 
cord and supraspinal structures. Stimulation of nociceptors by painful stimuli 
leads to continuous excitation resulting in sensitization. This  leads to 
decreased threshold, decreased response latency, increase in frequency of 
response and continuous excitation even after cessation of stimuli .If it occurs 
in the site of injury it is known as primary hyperalgesia and in uninjured 
tissues it is called secondary hyperalgesia. This response is mediated by 
bradykinin, histamine and leukotrienes[7] 
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Pathophysiology of pain 
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Gate control theory of pain: 
This was hypothesized by Ron Mezlack and Patrick in1962[8]. Pain 
perception is not due to direct activation of nociceptor alone and  is modulated 
by different neurons. Dorsal horn of spinal cord acts as a gate by either 
inhibiting or allowing conduction of pain impulses. Pain signals carried by 
small nerve fibres are allowed to pass through while those carried by large 
nerve fibres are blocked. 
Segmental inhibition: 
Glycine and GABA are the inhibitory neurotransmitters which mediate 
segmental inhibition through GABA-B receptor activity thereby increasing 
potassium movement across the  cell membrane. 
Supraspinal inhibition: 
Structures involved in supraspinal inhibition are periaqueductal gray, 
reticular formation and nucleus raphe magnus. Fibres from these sites act 
presynaptically on first order neurons and post synaptically on second order 
neurons. In this process monoamines like nor-adrenaline and serotonin act as 
neurotransmitters on spinal inhibitory interneurons to produce analgesia. 
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MULTIMODAL ANALGESIA 
 
Kehlet and Dahl described the concept of combining multiple analgesic 
technique in 1993, to improve outcome following surgery[9]. This was 
introduced to maximize analgesic benefits and reduce the incidence of opioid- 
related adverse effects. Multimodal analgesia is achieved by combining 
different analgesics that act by different mechanisms at different sites in the 
nervous system, so that adequate analgesia is attained with lower doses and 
reduced incidence of side effects. 
For maximum benefit, pain management must be initiated in the 
preoperative period itself , continued intra operatively and in the postoperative 
period. Also it is found to be  effective in patients who are at risk of side 
effects with large doses of opioids such as the elderly, patients with 
obstructive sleep apnea and chronic pain. 
 
BENEFITS 
1.Effective analgesia due to synergistic action. 
2.Less side effects due to lower dosage of drug used. 
 3.Faster recovery 
 
MODES OF INTERVENTION 
 Acts by reducing nociceptive input 
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1.Peripherally acting drugs 
A) Local anaesthetics: Local infiltration, Nerve Blocks, Spinal/Epidural 
blockade 
B)  NSAIDS: Cycloxygenase inhibitors 
C) Glucocorticoids 
 
2.Drugs acting in spinal cord 
A) Opiates 
B) NSAIDS 
C) NMDA receptor antagonist 
D) Gabapentinoids: gabapentin, pregabalin 
 
3.Drugs acting centrally: 
A) Opiates 
B) Acetaminophen 
 
4.Drugs acting on descending pain pathway: 
A) Tramadol 
B) Alpha 2 agonists 
C) 5 HT3 antagonists 
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                         MULTIMODAL ANALGESIA 
 
 
 
 
 
 
 
  
15 
 
 
PRE-EMPTIVE ANALGESIA 
 
The concept of pain prevention was first introduced by Crile in 1913 
and later developed by Wall and Woolf[10]. Pre-emptive analgesia is an anti 
nociceptive treatment that prevents establishment of altered processing of 
afferent input which amplifies postoperative pain. 
 
GOALS 
 1.Prevents pain related pathologic modulation of central nervous system. 
 2.Decreases acute pain after tissue injury. 
3.Inhibits persistence of post operative pain and development of chronic 
pain. 
Effective preemptive analgesia uses multiple pharmacological agents to 
reduce nociceptor activation either by blocking or decreasing receptor 
activation and by inhibiting the production or activation of pain 
neurotransmitters. 
Pain sensation from damaged tissues initiates a cascade of alterations in 
somatosensory system leading to increased responsiveness of both central and 
peripheral neurons. Due to these alterations, response to subsequent stimuli is 
increased thus amplifying pain. In preemptive analgesia, anti nociceptive 
treatment is started before the onset of pain stimulus and is operational during 
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the surgical procedure so that the physiological consequences of nociceptive 
transmission are reduced. Hence, preemptive analgesia is more effective than 
analgesic treatment initiated after surgery. It also reduces immediate post 
operative pain and prevents the development of chronic pain. Preemptive 
analgesia helps to prevent the neurological and biochemical consequences of 
noxious input to central nervous system. 
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PHARMACOLOGY OF GABAPENTIN 
 
Gabapentin, a second generation anticonvulsant drug was introduced in 
1993 for treatment of refractory partial seizures[11]. Later it was found to be 
effective in treating chronic pain conditions like post herpetic neuralgia, 
diabetic neuropathy, trigeminal neuralgia, HIV- related neuropathy, complex 
regional pain syndromes, inflammatory pain and malignant pain. Recently its 
use has been extended for management of postoperative pain. 
 
Chemistry 
Gabapentin,- 1-(amino methyl) cyclohexane  acetic acid is a structural 
analogue of Gamma amino butyric acid (GABA), an inhibitory 
neurotransmitter. It is a white crystalline solid, highly charged at physiological  
pH and is freely soluble in water. 
Molecular formula: C9 H17 NO2 
Molecular weight: 171.24 
P Ka1: 3.7 
PKa2: 10.7 
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PHARMACOKINETICS 
Oral bioavailability 
Absorption of gabapentin is not dose dependant, because of a saturable 
L-aminoacid transport mechanism in the intestine. Hence oral bioavailability 
varies inversely with dosage. After a single dose of 300 and 600mg, 
bioavailability was found to be 60% and 40% respectively. 
 
DISTRIBUTION 
Extensively distributed in human tissues and fluid after administration. 
Volume of distribution is 0.6-0.8l/Kg. Concentration in adipose tissue is low 
because it is highly ionized at physiological pH. Less that 30% is bound to 
plasma proteins. Concentration in cerebrospinal fluid is 5-35% of those in 
plasma and in brain tissue it is 80% of those in plasma. After oral intake, peak 
plasma concentration is reached in 2-3 hours. 
 
METABOLISM 
Gabapentin is not metabolized in human body. Does not induce hepatic 
microsomal enzymes. 
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ELIMINATION 
It gets eliminated unchanged in urine and the unabsorbed drug is 
excreted in faeces and renal clearance is related in a linear manner to 
creatinine clearance. Elimination half-life is 5-7 hours in patients with normal 
renal function and is unchanged by dose. It can be removed by hemodialysis. 
 
DRUG INTERACTION 
Cimetidine, a H2 receptor blocker decreases renal clearance when given 
concurrently. 
Antacids reduce the bioavailability of gabapentin when given 
concurrently. 
 
SPECIAL SITUATIONS 
RENAL INSUFFICIENCY: 
The half life of gabapentin is increased in patients with reduced creatinine 
clearance. Hence dose adjustment is necessary. 
HEMODIALYSIS 
In patients on dialysis, the half life of gabapentin is reduced. 
AGE 
With increasing age, renal clearance decreases. Hence reduction of dose 
is required in patients who have age related decline in renal function. 
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GENDER 
Pharmacokinetic parameters for male and female are similar and hence 
there is no significant gender differences. 
PREGNANCY & LACTATION 
Gabapentin has been assigned to pregnancy category C. Animal studies 
have revealed fetal toxicity involving delayed ossification of several bones. 
There is no controlled data in human pregnancy. Gabapentin should be given 
when benefit outweighs risk. Gabapentin is secreted into human milk, hence 
used only when benefits outweigh  the risk. 
 
ANTI-NOCICEPTIVE MECHANISM 
The exact mechanism is not known but most likely the anti nociceptive 
target of gabapentin is voltage gated calcium channels which are upregulated 
in the dorsal root ganglia and spinal cord after surgical trauma. 
Gabapentin selectively binds to α2δ subunit of voltage gated calcium 
channels and inhibits calcium influx through these channels thereby inhibiting 
the release of excitatory neurotransmitters (glutamate, aspartate, substance P, 
calcitonin gene related peptide) from the primary afferent nerve fibres in the 
pain pathway. 
Gabapentin does not affect the nociceptive threshold but has anti-
allodynic and anti-hyperalgesic properties. Gabapentin activates the 
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descending  nor adrenergic system and produces spinal nor epinephrine 
release, which acts on spinal α2 adrenoreceptor to produce analgesia. 
 
Perioperative benefits  
All perioperative applications are “off label” uses 
Gabapentin 
- provides perioperative  anxiolysis 
-It produces post operative analgesia 
-It attenuates  haemodynamic response to laryngoscopy and intubation 
-It prevents chronic post surgical pain, postoperative nausea, vomiting 
and delirium. 
 
ADVERSE EFFECTS 
Sedation and dizziness are most common. 
Asthesia, headache, nausea, ataxia, weight gain and amblyopia are other 
side effects. 
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PHARMACOLOGY OF PREGABALIN 
Pregabalin, or S-(+)-3-isobutylgaba, was designed as a lipophilic 
analogue of GABA substituted at the 3-position to facilitate diffusion across 
the blood–brain barrier.[12] 
 3-Isobutylgaba exists in isomeric forms, with S-(+)-3-isobutylgaba (or 
pregabalin) being the pharmacologically active enantiomer. Although 
pregabalin is structurally related to GABA, it is inactive at GABA receptors 
and does not appear to mimic GABA physiologically. Moreover, pregabalin 
does not have affinity for receptor sites or alter responses associated with the 
action of several common drugs for treating seizures or pain, which suggests 
that its mechanism of action is novel. Its pharmacological effects  result from 
its action as a ligand at the alpha-2- delta binding site, which is associated with 
voltage-gated calcium channels in the central nervous system 
(CNS).Pregabalin exhibits potent anticonvulsant, analgesic, and anxiolytic 
activity in various animal models 
 
ABSORPTION 
Pregabalin is rapidly and extensively absorbed after oral dosing in the 
fasting state, with maximal plasma concentrations occurring ∼1 h after single 
or multiple doses, and steady state being achieved within 24–48 h after 
repeated administration 
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Maximal plasma pregabalin concentrations (C max) and total exposures 
(AUC) are proportional to dose after either single or multiple dosing . The oral 
bioavailability is high at ≥90% and is independent of dose. The mean 
elimination t1/2 of pregabalin is 6.3 hours  and is also independent of dose and 
repeated drug administration . These findings of consistent dose-proportional 
pharmacokinetics, justify confidence in the prediction of dose–response 
relationships in clinical practice. In addition, the concentration–time profiles 
of pregabalin are similar after two- or three-times daily administration, which 
reflects the clinical findings that pregabalin administered via either dosing 
regimen resulted in similar efficacy. Moreover, the administration of 
pregabalin with food has no clinically relevant effect on the amount of 
pregabalin absorbed ,thus providing  a dosing regimen that is uncomplicated 
by meals. 
 
DISTRIBUTION, METABOLISM AND ELIMINATION 
Pregabalin is a substrate of the system L transporter, which is 
responsible for the transport of large amino acids across the brain and gut. 
Consistent with this, pregabalin has been shown to rapidly penetrate the 
blood–brain barrier in preclinical studies conducted in mice, rats, and 
monkeys. This is of obvious importance for a drug that influences CNS 
activity. Pregabalin undergoes negligible metabolism in humans. 
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LACK OF DRUG INTERACTIONS 
.  The pharmacokinetic profile of pregabalin indicates that it should have 
a very low potential for drug– drug interactions. Since pregabalin is neither 
metabolized nor bound to plasma protein, there is no rationale to expect drug–
drug interactions to occur via these mechanisms in clinical practice. 
Furthermore, studies using human liver microsomes have demonstrated that 
pregabalin does not affect the cytochrome P450 system at therapeutic doses, 
neither should it affect the metabolism of drugs eliminated via this route. As 
predicted from these findings, no drug interactions have been reported in 
pregabalin clinical studies to date, and none are anticipated in the future also. 
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POSTOPERATIVE PAIN ASSESSMENT METHODS 
It is very important and mandatory to assess the degree of pain 
experienced by the patient in the postoperative period. Pain assessment is 
considered as an important vital sign in postoperative patients which must be 
done periodically. Postoperative pain assessment involves preoperative 
education of the patient about pain following surgery.  
This preoperative education helps the patient to gain knowledge which 
alleviates the fear about pain and helps to reduce anxiety about pain. It also 
helps them to develop a positive approach towards pain thereby improving 
satisfaction of the patient. 
Postoperative pain assessment helps us to quantitate the intensity of pain, 
to formulate analgesic regimen and to assess the response to treatment given. 
There are a number of pain assessment methods but they must be simple and 
easily understandable by the patients.[13] 
 
Commonly used pain scales are 
• Visual analogue scale 
• Numerical rating scale 
• Verbal rating scale 
• Wong baker faces rating scale 
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Visual analogue scale: 
This scale is simple to use. It has a ten centimeter line with left end 
marked as no pain and right end marked as severe pain ever experienced. 
Patient is asked to mark a point on the line which corresponds to their pain 
intensity. Distance in centimeters recorded from left end of the line to upto  
patients mark is considered as the pain score. This scale is not useful in 
children, visually impaired persons and in those with cognitive impairment. 
 
 
Numerical rating scale: 
This scale closely resembles visual analogue scale. It consists of a ten 
centimeter line with left end marked as zero corresponding to no pain and, 
right end marked as ten corresponding to worst pain with numbers marked in 
between from one to nine. Thus it has eleven points on the scale. Patients are 
asked to point out a number on the scale which corresponds to their pain score. 
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Verbal rating scale: 
Here the patients are asked to express their pain verbally as no pain, 
mild pain, moderate pain and severe pain. Small changes in pain intensity 
cannot be made out in this scale. 
 
 
Wong baker faces rating scale: 
This scale is useful in persons who cannot communicate properly and 
in children less than seven years of age. 
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REVIEW OF LITERATURE 
1.Hill et al in 2001[15] conducted a trial comparing pregabalin to 
placebo and 400 mg of ibuprofen using a dental pain model. Study medication 
was administered postoperatively to patients who had undergone elective 
surgery to remove one or two third molars.  The study was done to  evaluate  
pregabalin at doses of 50 and 300 mg. Results proved that there were 
statistically significant differences in pain relief between the 300-mg 
pregabalin group and placebo. In addition, the 300-mg pregabalin group had a 
significantly longer duration of analgesia than the ibuprofen group and had the 
highest score on the patient global impression of study medication.  
2.Fassoulaki et al in 2002[22] compared the analgesic effects of 
gabapentine and mexiletine given as post operative pain relief in 75 patients 
undergoing breast cancer surgery. They were randomized in a double-blinded 
manner, to receive mexiletine 600 mg/d, gabapentin 1200 mg/d, or placebo for 
10 days. Anesthesia was standardized, and all patients had access to routine 
postoperative analgesics on demand. The visual analog scale score assessed 
pain at rest and after movement. Mexiletine and gabapentin reduced codeine 
consumption from the second to tenth day by 50% (P = 0.029; P = 0.018 and  
P = 0.035 for mexiletine versus control and gabapentin versus control 
comparisons, respectively). Total paracetamol consumption was also shown to 
be reduced during the same time (P = 0.0085; P = 0.007 and P = 0.011 for the 
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mexiletine and gabapentin groups when compared with the control, 
respectively). Pain at rest and after movement was reduced by both drugs on 
the third postoperative day. Pain after movement also was reduced by 
gabapentin between the second and fifth postoperative day. 
3.Jesper Dirks et al in 2002[28] conducted a study in patients 
undergoing mastectomy to evaluate the effectiveness of Gabapentin on 
postoperative pain. Patients were divided into two groups to receive 
Gabapentin 1200mg or Placebo one hour before surgery. A standard technique 
of anesthesia was practiced. Postoperatively the pain intensity score and 
analgesic requirement was recorded for all patients and was found that pain 
scores with movement were significantly decreased at 2nd and 4th post-
operative hours in patients who received Gabapentin. There was no difference 
in pain at rest and side effects between these groups. 
4.Turan et al in 2004[14] conducted a study to assess whether 
preoperative administration of Gabapentin has a role in reducing the VAS 
scores and Tramadol requirement in patients undergoing hysterectomy through 
abdominal approach. Post-operatively, all patients were given Tramadol for 
control of pain in a standard manner. All of them were monitored for total 
dosage of analgesic required and for their pain intensity scores. It was 
concluded that the Tramadol consumption and VAS scores were lower in 
Group G patients. 
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5.C.K.Pandey et al in 2004[21] conducted a study to find out the 
effectiveness of preoperative Gabapentin in controlling post-operative pain 
and analgesic requirement. Study was performed in patients undergoing 
Lumbar discectomy. They were divided into Group G who received 
gabapentin 300mg and Group P were given Placebo capsules before 2 hours of 
surgery. Fentanyl was given at a dose of 2mg/Kg on demand intravenously for 
effective control of postoperative pain. Patients were monitored post-
operatively for pain scores up to 24 hours. It was found that patients in Group 
G showed significantly lower pain scores and reduced requirement for 
Fentanyl in the postoperative period. 
6.Al Mujadi et al in 2006[23] conducted a  prospective, randomized, 
double-blind clinical trial, in which  gabapentin 1200 mg or placebo was given  
two hours prior to induction of anesthesia to patients undergoing elective 
thyroidectomy. Post-thyroidectomy pain was assessed on a visual analogue 
scale at rest and during swallowing in the first 24 hr postoperatively. All the 
patients received morphine 3 mg iv every 5 minutes until VAS scores were 4 
or less at rest, and 6 or less with swallowing. Total morphine consumption for 
each patient was recorded from zero to 24 hr postoperatively. Total 
postoperative morphine consumption in the gabapentin group was 
significantly less - 15.2 +/- 7.6 mg (mean +/- SD) vs 29.5 +/- 9.9 mg in the 
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placebo group (P < 0.001). No significant differences in side effects were 
observed between groups 
7. Dilek Memis et al [33] in 2006 conducted a study in patients 
undergoing endoscopic sinus surgery under local anesthesia. Patients were 
randomly allocated to receive Gabapentin 1200mg or Placebo Two hours 
before surgery. Diclofenac and Fentanyl was used to control intraoperative 
and postoperative pain. Sedation and pain intensity was assessed 
intraoperatively and postoperatively. It was found that Gabapentin group of 
patients had lower scores and analgesic requirement. They also found that 
dizziness is a common side effect of Gabapentin which limits its use in 
Ambulatory surgery. They found that time for first rescue analgesic was 
longer in Gabapentin group. 
8. Tiippana et al in 2007[19] selected 22 case studies on the 
preoperative administration of Gabapentin and their outcome was analyzed. It 
was found that one dose of Gabapentin ranging from 300-1200mg when given 
pre-operatively produced 20% to 60% of Opioid sparing effect. They also 
found that the dose of Gabapentin used did not have any effect on Opioid 
consumption in the post-operative period. The study revealed that the adverse 
effects of Opioids were significantly reduced by administration of Gabapentin 
per-operatively and sedation and dizziness were the most common side effects 
associated with use of Gabapentin. 
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9.Agarwal et al in 2008[20] conducted a  prospective, randomized 
placebo controlled, double-blind study in sixty adults (16–60 yr) with ASA 
physical status I and II, of either sex undergoing elective laparoscopic 
cholecystectomy .Patients were divided into two groups of 30 each to receive 
either a matching  placebo or pregabalin 150 mg, administered orally 1 h 
before surgery. Postoperative pain (static and dynamic) and postoperative 
patient-controlled fentanyl consumption were reduced in the pregabalin group 
compared with the placebo group (P,0.05). Side-effects were similar in both 
groups 
10.Saraswat et al. in 2008[16] conducted a study  to compare the 
efficacy of pregabalin and gabapentin with respect to increase in duration of 
analgesia, reduction in total post- operative requirements of analgesics and 
study side effects and complications. Sixty patients were randomly allocated 
to one of the two groups of thirty each. Patients in Group G were given single 
dose of gabapentin 1200mg, whereas in Group P were administered pregabalin 
300mg one hour prior to administration of spinal anaesthesia. The total 
postoperative analgesic time was 8.98h in Group G whereas 14.17h in Group 
P (HS, P < 0.001). Total dose of analgesics in first 24h was 62.5mg in Group 
P and 72.5mg in Group G and was not significant (P>.05)..Dizziness and 
somnolence were the only side effects noticed in both groups 
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11.Jokela et al in 2008[24] evaluated the control of pain after 
perioperative administration of pregabalin 300 or 600 mg, compared with 
diazepam 10mg in 91 women scheduled for laparoscopic hysterectomy. Until 
the 1st postoperative morning, analgesia was provided by oxycodone using 
patient controlled analgesia. The visual analogue scale scores for pain and side 
effects  and the amounts of the analgesics were recorded for three days after 
surgery. The doses of oxycodone during hours 0-12 after surgery were similar 
in the three groups, whereas the dose of oxycodone during hours 12-24 after 
surgery was smaller in the P600 group than in the P300 group (0.09 vs. 0.16 
mg kg(-1); P=0.025). The total dose of oxycodone (0-24h after surgery) was 
smaller in the P600 group than in the D10 group (0.34 vs. 0.45 mg kg(-1); 
P=0.046). 
12.Panah Khahi et al in 2011[25] conducted a study in patients 
undergoing orthopedic procedures involving  tibia under spinal anesthesia. 
Patients were divided into two groups. Groups G received Gabapentin 300mg 
and Group P received Placebo capsules orally two hours before surgery. All 
patients were monitored postoperatively for VAS scores and analgesic 
requirement upto 24 Hours. It was found that VAS scores were less in Group 
G patients at Two hours post-operatively. There was no significant difference 
in VAS scores at all other time intervals between Group G and Group P. They 
also found that Gabapentin did not produce any side effect at this dosage. 
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13.Anju Ghai et al in 2011[17] conducted a study in 90 women 
undergoing abdominal hysterectomy who were anaesthetized in a standardized 
fashion. Patients received 300 mg pregabalin, 900 mg gabapentin or placebo, 
1–2 hours prior to surgery. The primary outcome was analgesic consumption 
over 24 hours and patients were followed for pain scores, time to rescue 
analgesia and side effects as secondary outcomes. The diclofenac consumption 
was statistically significant between pregabalin and control groups, and 
gabapentin and control groups; however, pregabalin and gabapentin groups 
were comparable. Moreover, the consumption of tramadol was statistically 
significant among all the groups. Patients in pregabalin and gabapentin groups 
had lower pain scores in the initial hour of recovery. However, pain scores 
were subsequently similar in all the groups. Time to first request for analgesia 
was longer in pregabalin group followed by gabapentin and control groups. 
14.Rajendran et al in 2014[26] conducted a randomized double blind 
study in  90 patients undergoing lower abdominal and lower limb surgeries. 
Patients were divided into three groups. Group G received tab gabapentin 900 
mg, Group P received tab pregabalin 300 mg and Group C received placebo 
tablet orally 1 hour prior to surgery. All patients underwent surgery under 
spinal anesthesia using 0.5% Bupivacaine. Assessment of postoperative pain 
was made with visual Analogue Scale (VAS) score at 1, 2, 4, 6, 8,12, 18, and 
24 hours post operatively. Injection tramadol 100 mg was given as rescue 
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analgesic intramuscularly when VAS score was > 7 in all the groups. Time to 
first rescue analgesics and number of rescue analgesics received were noted in 
all groups. The occurrences of side effects were noted in all groups. It was 
found that the tramadol as rescue analgesia consumption was less in 
pregabalin and gabapentin groups compared to control and was statistically 
significan  (P < 0.001). Initial VAS scores were lower in pregabalin (3.2 ± 0.4) 
and gabapentin (3.63 ± 0.32) groups compared to control (6.60 ± 0.77) and 
was statistically significant (P < 0.001). Time to first rescue analgesia was 
significantly longer for pregabalin (24.6 hours) followed by gabapentin (20.76 
hours) and control (4.93 hours) groups. 
15.Montaser et al in 2016[18]  conducted a study in which Sixty 
patients undergoing radical cystectomy were randomized into 4 groups: Group 
I: control (placebo) group, Group II: received pregabalin 300 mg  2 h 
preoperatively, Group III: received pregabalin 300 mg 2 h preoperatively and 
12 h thereafter, Group IV: received pregabalin 600 mg 2 h preoperatively. 
Postoperative pain, time to first request of analgesia, and total morphine 
consumption were recorded. Results: VAS was significantly reduced in groups 
II, III, IV in comparison with group I immediately postoperative, and after 2 h 
(P < 0.05). Sedation score was significantly higher in groups II, III, IV 
compared to group I immediately postoperative (P < 0.05). First request of 
analgesia was significantly delayed in groups II, III, IV compared to control 
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group (P = 0.000). Total analgesic consumption was significantly reduced in 
groups II, III, IV compared to group I (P = 0.000). Group IV showed a 
significantly higher incidence of dizziness compared to group I. Conclusion: 
Peri-operative pregabalin at doses of 300 mg and 600 mg reduced 
postoperative opioid consumption and prolonged time to first request of 
analgesia and a single preoperative dose of 600 mg is superior in analgesia to 
others, without serious side effect 
16. Anil Verma et al[34] conducted a study in patients undergoing 
abdominal hysterectomy under combined spinal epidural anesthesia. Patients 
were divided into two groups and were given Gabapentin 300mg or Placebo 
Two hours before surgery. Postoperatively analgesia was provided with 
0.125% Bupivacaine epidurally on demand. The pain scores and number of 
epidural boluses received were recorded for all patients. It was found that the 
Gabapentin group had lower VAS scores and less number of epidural boluses 
to control post-operative pain.                                                      
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MATERIALS AND METHODS 
 
This study was a randomized, single blinded, prospective study 
conducted at the Department of Anaesthesiology, Thanjavur Medical College 
in association with the Department of Orthopaedics, Thanjavur Medical 
College. 
Institutional Ethics Committee approval was obtained. 
 
INCLUSION CRITERIA: 
1. Patients undergoing elective lower limb surgeries under department of 
orthopaedics 
2. American Society of  Anaesthesiologists (ASA) physical status I and 
II patients 
3. Age group 18 to 60 years 
4. Male and female 
 
EXCLUSION CRITERIA: 
1. Patient refusal 
2. History of allergy to gabapentin and pregabalin 
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3. History of drug and /or alcohol abuse 
4. Patients who have been prescribed pregabalin or gabapentin for other 
indications 
5. History of chronic pain and chronic daily intake of analgesics 
6. History of epilepsy and other neurological disorders 
7. Pregnancy and breast feeding mothers 
8. Liver or renal disease 
Patients satisfying inclusion criteria were randomly allocated by closed 
envelope method into three groups: Group P (Pregabalin group), Group G 
(gabapentin group) and Group C (placebo group). They were informed 
preoperatively about the visual analogue scale. 
Patients in  Group P received 300 mg of Pregabalin orally, Group G 
received Gabapentin 900mg orally and Group C patients received placebo 
capsules with sips of water two hours before surgery.  
Inside the operating room, monitors (ECG, NIBP, Pulse oximeter) were 
connected. Bladder was catheterized to monitor urine output. Intravenous 
access established with 18G cannula. 
All patients were preloaded with 10ml/kg of Ringer’s lactate solution. 
Under strict aseptic precautions, 3ml of hyperbaric solution of 0.5% 
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bupivacaine with 25mcg of Inj Fentanyl was given in lumbar subarachnoid 
space using  25 Gauge Quincke needle. 
At the end of surgery, patients were shifted to ward. VAS scores were 
assessed in the immediate postoperative period (0hr) and at 1, 2,3, 4, 6, 9,12 
and 24 hours post operatively. Patients were given Inj.Tramadol 2mg/kg 
intramuscularly when the VAS score was 4 or greater. Dosage did not exceed 
250 mg at one time and 600 mg per day. Time since spinal anaesthesia to first 
requirement of analgesic (T1), Total analgesic requirement in first 24 hours, 
VAS scores, Ramsay sedation score, side effects of the drug like dizziness, 
confusion, nausea, vomiting were recorded in first 24 hours postoperatively. 
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RESULTS 
                              
 Ninety patients posted for orthopaedic lower limb surgeries of ASA            
I & II were taken up for the study. They were allocated randomly in a single - 
blind fashion into three groups in equal number of 30 each. Group C (placebo) 
received  tablets of alike looking placebo, Group G (Gabapentin) received  
900mg tablets of gabapentin,Group P (Pregabalin) received 300mg tablets of 
pregabalin  60 minutes prior to anaesthesia .A standard anaesthetic technique 
was followed in all patients. The patients were assessed by an observer in the 
postoperative period who was blinded for the group 
At the end of study the data collected was analysed using statistical 
software package SPSS 20.0 . Data was analysed using one way analysis of 
variance(ANOVA),T test(within groups) and chi-square test. The results are 
expressed in terms of mean and standard deviation. P value of less than 0.05 is 
considered to be statistically significant.  
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Table 1: AGE DISTRIBUTION 
 
Age in 
Years 
 
 
Group    P 
 
Group  G Group   C 
Number 
 
% 
 
Number % Number % 
18-20 
 
3 10 4 13 2 7 
21-30 
 
5 17 7 23 10 33 
31-40 
 
3 10 5 17 5 17 
41-50 
 
10 33 5 17 3 10 
51-60 
 
9 30 9 30 10 33 
TOTAL 
 
30 100 30 100 30 100 
Range 30-55 30-50 30-50 
Mean 42.30 40.30 40.17 
SD 14.317 13.543 14.749 
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Figure 1:Age Distribution 
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Table 1 shows the age distribution of the patients in all the three groups.The 
minimum age in Group P (Pregabalin group),Group G (Gabapentin group) and 
Group C (Placebo group) was 18 years.The mean age in Group P was 
42.30±14.31 years, Group G was 38.30± 13.54 years and Group C was 40.17 
±14.74 years .There was no statistical significance between the age 
distribution in all 3 groups(p>0.05).The three groups were comparable in age 
distribution 
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Table 2: Sex distribution 
Group P (n=30) Group G (n=30) Group C (n=30) 
Male 
 
Female 
 
Male Female Male Female 
28 
 
2 
 
29 
 
1 28 
 
2 
 
 
 
Figure 2: Sex distribution 
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Table 2  and  figure 2 show the gender distribution of all the patients in 
the three groups.There is no significant difference in the sex distribution 
between the three groups.(P>0.05) 
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Table 3: Height distribution 
 
 
Height 
in cm 
 
Group P 
 
Group G 
 
Group C 
Number % Number % Number % 
 
141-150 
 
2 7 0 0 1 3 
 
151-160 
 
12 40 16 53 8 27 
 
161-170 
 
16 53 14 47 19 63 
 
171-180 
 
0 0 0 0 2 7 
 
TOTAL 
 
30 100 30 100 30 100 
Range 150-170 149-172 150-172 
Mean 161.70 160.77 163.30 
SD 4.647 4.158 4.907 
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Figure 2: Height distribution 
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Table 3 and Figure 3 show the height distribution of patients.The mean 
height in Group P was 161.70± 4.647 cm,Group G was 160.77±4.158 cm and 
Group C was 163.30±4.907cm.There was no significant difference in the 
height of patients among the three groups .(P>0.05) 
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Table 4: Weight distribution 
 
Weight in kg 
Group P Group G Group C 
Mean 58.27 58.90 60.53 
SD 6.596 6.804 6.394 
Range 50-65 50-65 50-70 
 
Figure 4: Weight distribution 
 
Table 4 shows the body weight distribution of patients.The mean body 
weight in Group P (Pregabalin group) was 58.27±6.596 kg, in Group G 
(Gabapentin group) was 58.90±6.804 kg and Group C( Placebo group) was 
60.53±6.394 kg. The minimum body weight was 45 kg and the maximum 
weight was 72 kg.There was no significant difference in the body weight of 
patients among the three groups.(P>0.05) 
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Table 5: Duration of surgery 
 
Duration in 
minutes 
 
 
Group P 
 
Group G 
 
Group C 
 
Mean 
 
 
129 
 
130.83 
 
128.33 
 
Range 
 
 
90-180 
 
90-180 
 
90-170 
SD 21.27 21.959 17.847 
 
Figure 5:   Duration of surgery  
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Table 5 and figure 5 show the mean duration of surgery in minutes in the three 
groups .The mean duration of surgery was 129 minutes with standard 
deviation(SD) of 21 for Group P,130.83 minutes with SD of 21 for Group G 
and 128.33 minutes with SD of 17 for Group C. There was no statistical 
significance among the three groups .(P>0.05)Thus the three groups were 
comparable with  regard to duration of surgery 
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Table 6: Visual analogue scale (VAS) score of Group P vs Group C 
 
VAS 
 
Group P 
Mean (SD) 
 
Group C 
Mean(SD) 
 
P value 
 
0 hour 
 
1.83(0.507) 
 
2.03(0.346) 
P.08>0.05 
Not Significant 
 
1 hour 
 
1.86( 0.346) 
 
3.0 (0.910) 
P.000<0.05 
Significant 
 
2 hours 
 
1.93(0.254 ) 
 
3.96(0.928 ) 
P.000<0.05 
Significant 
 
3 hours 
 
2.0( 0.263) 
 
5.1( 1.094) 
P.000<0.05 
Significant 
 
4 hours 
 
2.6( 0.770) 
 
5.2( 0.379) 
P.015<0.05 
Significant 
 
6 hours 
 
2.96( 1.098) 
 
5.7( 0.556) 
P.000<0.05 
Significant 
 
9 hours 
 
2.86( 0.944) 
 
5.4( 1.192) 
P.038<0.05      
Significant 
 
12 hours 
 
2.83( 0.913) 
 
5.13( 1.008) 
P.039<0.05. 
Significant 
 
24 hours 
 
3.43( 1.073) 
 
5.8( 0.664) 
P.000<0.05 
Significant 
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Figure 6: Visual analogue scale (VAS) score of Group P vs Group C 
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All patients were monitored for VAS scores at rest in the immediate 
postoperative period (0 hr), at 1, 2, 4, 6,9 12, and 24 hours postoperatively. In 
the immediate postoperative period (0 hr),the mean VAS score was found to 
be 1.83 in Group P  and 2.03 in Group C  with no  statistically significant 
difference between the groups. This may be due to the effect of spinal 
anaesthesia.  
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The mean VAS scores during postoperative period of 1, 2, 4, 6,9, 12 and 
24 hours in group P patients were 1.86,1.93,2,2.6,3.36,3,2.83and 3.43 
respectively 
 
In Group C patients the mean VAS scores were 3,3.96, 5.1,5.2. 5.7, 5.4, 
5.13 and 5.8 respectively. In all these time intervals ,the P value was less than 
0.05 which is highly significant. This shows that there is a significant 
reduction in the mean VAS scores in patients receiving pregabalin 
premedication compared to control in the first 24 hours after surgery 
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Table 7: Visual analogue scale (VAS) score of Group G vs Group C 
 
VAS 
 
Group G 
Mean (SD) 
 
Group C 
Mean(SD) 
 
P value 
 
0 hour 
 
1.93(0.254) 
 
2.03(0.346) 
P.07>0.05 
Not Significant 
 
1 hour 
 
1.97( 0.183) 
 
3.0 (0.910) 
P.000<0.05     
Significant 
 
2 hours 
 
1.97(0.183 ) 
 
3.96(0.928 ) 
P.000<0.05 
Significant 
 
3 hours 
 
2.0( 0.00) 
 
5.1( 1.094) 
P.000<0.05 
Significant 
 
4 hours 
 
2.76( 1.104) 
 
5.2( 0.379) 
P.007<0.05 
Significant 
 
6 hours 
 
2.87( 0.937) 
 
5.7( 0.556) 
P.015<0.05 
Significant 
 
9 hours 
 
2.76( 1.022) 
 
5.4( 1.192) 
P.018<0.05 
Significant 
 
12 hours 
 
2.76( 0.898) 
 
5.13( 1.008) 
P.025<0.05. 
Significant 
 
24 hours 
 
3.36( 0.980) 
 
5.8( 0.664) 
P.000<0.05 
Significant 
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Figure 7: Visual analogue scale (VAS) score of Group G vs Group C  
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In the immediate postoperative period (0 hr),the mean VAS score was 
found to be 1.93 in Group G  and 2.03 in Group C  with no  statistically 
significant difference between the groups. This may be due to the effect of 
spinal anaesthesia. The mean VAS scores during postoperative period of 1, 2, 
4,6,9,12 and 24 hours in group G patients were 1.97,1.97,2,2.76,2.87,2.76,2.56 
and 3.26 respectively. In Group C patients the mean VAS scores were 3,3.96, 
5.1, 5.2. 5.7, 5.4, 5.13 and 5.8 respectively. In all these time intervals, the P 
value was less than 0.05 which is highly significant.This shows that there is a 
significant reduction in the mean VAS scores in patients receiving gabapentin 
premedication compared to control in the first 24 hours after surgery 
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Table 8: Visual analogue scale (VAS) score of Group P vs Group G 
 
VAS 
 
Group P 
Mean (SD) 
 
Group G 
Mean (SD) 
 
P value 
 
0 hour 
 
1.83(0.507) 
 
1.93(0.254) 
P.07>0.05 
Not 
Significant 
 
1 hour 
 
1.86( 0.346) 
 
1.97( 0.183) 
P.167>0.05 
Not 
Significant 
 
2 hours 
 
1.93(0.254 ) 
 
1.97(0.183 ) 
P.561>0.05 
Not 
Significant 
 
3 hours 
 
2.0( 0.263) 
 
2.0( 0.00) 
P1.000>0.05 
Not 
Significant 
 
4 hours 
 
2.6( 0.770) 
 
2.76( 1.104) 
P.500>0.05 
Not 
Significant 
 
6 hours 
 
2.96( 1.098) 
 
2.87( 0.937) 
P.063>0.05 
Not 
Significant 
 
9 hours 
 
2.86( 0.944) 
 
2.76( 1.022) 
P.362>0.05 
Not 
Significant 
 
12 hours 
 
2.83( 0.913) 
 
2.76( 0.898) 
P.259>0.05 
Not 
Significant 
 
24 hours 
 
3.43( 1.073) 
 
3.36( 0.980) 
P.532>0.05 
Not 
Significant 
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Figure 8: Visual analogue scale (VAS) score of Group P vs Group G  
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The mean VAS scores during postoperative period of 0,1, 2, 4, 6,9, 12 
and 24 hours in group P patients were 1.83, 1.86,1.93,2,2.6,3.36,3,2.83and 
3.43 respectively 
In Group G patients the mean VAS scores were 1.93,1.97,1.97,2,2.76, 
2.87, 2.76, 2.76  and 3.26 respectively. The P value at all these time intervals 
was > 0.05 which was not statistically significant. This shows that there is no 
significant difference between the analgesic properties of  pregabalin and 
gabapentin. 
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Table 9: Ramsay sedation score. Group P vs Group C 
 
Time 
 
Group P 
Mean (SD) 
 
Group C 
Mean(SD) 
 
Pvalue 
 
0 hour 
 
2.60(0.312) 
 
2.0(0) 
P.004<0.05 
Significant 
 
1 hour 
 
2.4(0.123) 
 
1.7(.466) 
P.001<0.05 
Significant 
 
2 hours 
 
2.3(0.325) 
 
1.7(.466) 
P.001<0.05 
Significant 
 
3 hours 
 
1.96(.183) 
 
1.6(.498) 
P.000<0.05 
Significant 
 
4 hours 
 
1.9(.305) 1.73(.450) 
P.018<0.05 
Significant 
 
6 hours 
 
1.83(.490) 
 
1.40(.498) 
P.000<0.05 
Significant 
 
9 hours 
 
1.7(.466) 
 
1.43(.504) 
P.078>0.05 
Not Significant 
 
12 hours 
 
1.76(.430) 
 
1.63(.490) 
P.267>0.05 
Not Significant 
 
24 hours 
 
1.50(.509) 
 
1.56(.254) 
P.345>0.05 
Not Significant 
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Figure 9: Ramsay sedation score.Group P vs Group C 
0
1
2
3
0hr 1hr 2hr 3hr 4hr 6hr 9hr 12hr 24hr
Group P
Group C
R
a
m
sa
y
 s
e
d
a
ti
o
n
 s
co
re
 
Postoperatively all patients were assessed for the level of sedation using 
Ramsay sedation score periodically at 0, 1, 2, 4, 6, 9,12, and 24 hours. The 
mean sedation scores at 0, 1, 2,3, 4, 6 hours of postoperative period in group P 
were 2.6, 2.4, 2.3, 1.96, 1.9, 1.83.In Group C, the scores were 
2,1.7,1.7,1.6,1.73 and 1.4 respectively. The P value at all time intervals upto   
6 hrs was less than 0.05 which was highly significant. 
This shows that the level of sedation was significantly higher in group P 
patients compared to Group C upto 6 hours in the postoperative period. 
However, the scores at 9,12 and 24 hrs were not statistically significant 
among the 2 groups. This shows that the sedation effect of pregabalin is not 
significant beyond 6 hrs postoperatively 
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Table 10: Ramsay sedation score. Group G vs Group C 
 
Time 
 
Group G 
Mean(SD) 
 
Group C 
Mean(SD) 
 
P value 
 
0 hour 
 
2.73(.407) 
 
2.0(0) 
P.000<0.05 
Significant 
 
1 hour 
 
2.5(.498) 
 
1.7(.466) 
P.000<0.05 
Significant 
 
2 hours 
 
2.4(.305) 
 
1.7(.466) 
P.000<0.05 
Significant 
 
3 hours 
 
2.2(.183) 
 
1.6(.498) 
P.000<0.05 
Significant 
 
4 hours 
 
2.00(0) 1.73(.450) 
P.002<0.05 
Significant 
 
6 hours 
 
1.87(0.183) 
 
1.40(.498) 
P.001<0.05 
Significant 
 
9 hours 
 
1.66(.479) 
 
1.43(.504) 
P.071>0.05 
Not Significant 
 
12 hours 
 
1.83(.592) 
 
1.63(.490) 
P.159>0.05 
Not Significant 
 
24 hours 
 
1.53(.681) 
 
1.56(.254) 
P.16>0.05 
Not Significant 
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Figure 10: Ramsay sedation score.Group G vs Group C 
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The mean sedation scores at 0, 1, 2,3, 4, 6 hours of postoperative period 
in group G were 2.73,2.5, 2.4, 2.2, 2, and 1.97 respectively.  In Group C, the 
scores were 2,1.7,1.7,1.6,1.73 and 1.4 respectively .The P value at all time 
intervals upto 6 hrs was less than 0.05 which is highly significant  
This shows that the level of sedation was significantly higher in group G 
patients compared to Group C upto 6 hours in the postoperative period. 
However, the scores at 9,12 and 24 hrs were not statistically significant among 
the 2 groups. This shows that the sedation effect of gabapentin is not 
significant beyond 6 hrs postoperatively 
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Table 11: Ramsay sedation score. Group P vs Group G 
 
Time 
 
Group P 
Mean (SD) 
 
Group G 
Mean(SD) 
 
 Pvalue 
 
0 hour 
 
2.60(0.312) 
 
2.73(.407) 
P.261>0.05 
Not Significant 
 
1 hour 
 
2.4(0.123) 
 
2.5(.498) 
P.352>0.05 
Not Significant 
 
2 hours 
 
2.3(0.325) 
 
2.4(.305) 
P.078>0.05 
Not Significant 
 
3 hours 
 
1.96(.183) 
 
2.2(.183) 
P.98>0.05 
Not Significant 
 
4 hours 
 
1.9(.305) 
 
2.00(0) 
P.73>0.05 
Not Significant 
 
6 hours 
 
1.83(.490) 
 
1.87(0.183) 
P.786>0.05 
Not Significant 
 
9 hours 
 
1.7(.466) 
 
1.66(.479) 
P.620>0.05 
Not Significant 
 
12 hours 
 
1.76(.430) 
 
1.83(.592) 
P.831>0.05 
Not Significant 
 
24 hours 
 
1.50(.509) 
 
1.53(.681) 
P.405>0.05 
Not Significant 
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Figure 11: Ramsay sedation score. Group P vs Group G 
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The mean sedation scores of Group P and Group C at all time intervals were 
comparable as the P value was greater than 0.05.Hence, Pregabalin and 
Gabapentin have similar sedating effects in the post operative period   
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Table 12: Time of rescue analgesic (T1) 
 
Duration in 
minutes from 
the end of 
surgery 
 
 
Group P 
 
Group G 
 
Group C P value 
 
Mean 
 
 
502.3 382.6 137.8 
 
 
 
0.000 
 
SD 101.087 119.162 
 
44.483 
 
 
Range 
 
 
220-550 
 
220-570 
 
60-205 
 
Figure 12: Time of rescue analgesic (T1) 
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Postoperatively all patients were monitored for VAS scores periodically. 
When the VAS score at rest is 4 or greater, patients were given Tramadol 
2mg/kg intravenously as initial dose. So T1 is the time interval between 
providing spinal anaesthesia and administration of first dose of tramadol. It 
was found that this Time interval was 137.8minutes in group C, 502.3 minutes 
in Group P and 382.6minutes in group G. The P value was found to be 0.00, 
which is considered significant. This indicates that T1 score was significantly 
greater in group C compared to group P and Group G. Hence Gabapentin and 
Pregabalin give prolonged post operative pain relief compared to control 
 
The T 1 score of Pregabalin group was found to be greater than that of 
gabapentin with a P value.016 <0.05 which was highly significant. Hence 
Pregabalin provides more prolonged pain relief compared to gabapentin 
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Table 13: Total dose of  Tramadol administered in 24 hours post surgery 
 
Dose in mg 
 
 
Group P 
 
GroupG 
 
Group C 
 
 
 
 
P.000<0.05 
Significant 
 
Mean(SD) 
 
 
170(46.609) 
 
176.7(50.401) 286.7(34.575) 
 
Range 
 
 
100-200 
 
100-300 
 
100-300 
 
 
Figure 13: Total dose of  Tramadol administered in 24 hours post surgery 
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Postoperative analgesia was provided with intravenous tramadol for all 
patients. Initial dose of tramadol is 2mg/kg intravenously, when patient’s VAS 
score is 4 or more. Subsequently tramadol was given at a dose of 2 mg/kg 
when the VAS score was 4 or more, or on patients demand. Care was taken 
not to exceed the limit of 250mg/dose and 600mg/day. Total dosage of 
Tramadol required for each patient during postoperative period upto 24 hours 
was calculated.  In group C patients, average dose of tramadol required was 
286.7 mg In group P, the dosage required was 170mg.In group G the dosage 
required was 176.7mg. The P value was found to be 0.000 which is highly 
significant.. Hence it was found that total tramadol consumption was 
significantly lower in group P and group G patients compared to group C. 
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Table 14   :Incidence of adverse effects 
 
 
Adverse 
effects 
 
Group 
P(n=30) 
 
GroupG(n=30) 
 
Group 
C(n=30) 
 
Nausea 
 
 
 
    0 
 
2 
 
5(16%) 
 
Vomiting 
 
 
 
0 
 
0 
 
3(10%) 
 
 
Giddiness 
 
 
4(13%) 
 
3 (10%) 
 
0 
 
Figure 14: Incidence of adverse effects 
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Table 14  and  figure 14  show the incidence of side effects in the three groups. 
In group G, 3 patients complained of giddiness and 2 complained of nausea 
while in Group P, only 4 patient had giddiness. These values were not 
statistically significant .This implies that  Pregabalin and gabapentin do not 
cause any significant side effects. In group C, 5 patients  had nausea and 3 
patients had vomiting. This may be due to increased doses of tramadol in the 
placebo group. 
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DISCUSSION 
 
 Post operative pain is the reason for several complications like delayed 
recovery,metabolic alterations,anxiety and stress to the patients and patient 
dissatisfaction. Hence several studies have been conducted to identify the best 
methods of providing  post operative pain relief. The concept of preemptive 
analgesia introduced by Crile and further developed by Wall and Woolf  
revolutionized  post operative pain relief[10]. Kehlet and Dahl developed the 
concept of multimodal analgesia[9] to reduce the dosage of opioids in patients 
who are at a high risk of developing chronic pain. The main aim of 
multimodal analgesia is to reduce the dosage and side effects  of opioids by 
replacing with drugs which act by different mechanisms.  Gabapentinoids  
have been found to be very effective in this role . This was the basis of this 
study . 
This study was a prospective ,randomized, single  blinded  study  
conducted by the Department of Anaesthesiology, Thanjavur medical college 
in collaboration with Department of Orthopaedics,.In this study,90 patients 
undergoing lower limb orthopaedic  surgeries under spinal anaesthesia were 
enrolled and randomly allocated into 3 groups-Group P received Pregabalin 
300mg,Group G patients received Gabapentin 900mg and Group C received 
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placebo. This is similar to a study conducted by Rajendran et al [26], 90 patients 
undergoing lower abdominal surgeries were selected and allocated into 3 
groups  (Pregabalin group,Gabapentin group and Placebo group) with similar 
dosage of drugs. 
The study was conducted in orthopaedic patients because  orthopaedic  
surgeries are considered one of the most painful procedures in the post 
operative  period  as described by Beaussier et al [27] 
DOSAGE OF DRUGS 
In this study, oral Gabapentin was given in the dosage of 900 mg and 
Pregabalin was given in the dosage of 300 mg. This was similar to the study 
conducted by Rajendran et al. Schmidt et al in 2013[30]  evaluated  many 
studies and postulated that higher doses of gabapentin (upto 1200 mg) and 
Pregabalin (upto 300 mg ) were more clinically significant in reducing post 
operative pain than lower doses. This was the reason why 300mg of 
Pregabalin and 900 mg of Gabapentin were compared in this study. 
Jokela et al[24]  observed that analgesia was better after premedication 
with pregabalin 150 mg in patients undergoing day-case gynaecological 
laparoscopic surgery. Hence the drugs were given preoperatively in this study. 
Paech et al[29]  reported that a single preoperative dose of 100 mg 
pregabalin was ineffective in reducing acute postoperative pain or improving 
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recovery after minor surgery involving only the uterus. Khan et al[32] studied 
175 patients undergoing lumbar laminectomy and found that patients who 
received either 900 or 1,200mg of gabapentin (either pre- or postoperatively) 
had lower pain scores throughout the entire first 24h than patients who 
received either placebo or 600mg of gabapentin.CK Pandey et al[21] conducted 
a study  in 100 patients undergoing lumbar discectomy in which the authors 
found that patients who received either 600, 900, or 1,200mg of gabapentin 
had better pain scores at all time points than those receiving either placebo or 
gabapentin 300mg.This correlates with the findings in this study. 
 
TIMING OF DRUGS: 
The drugs were given preoperatively .This is based on the study conducted by 
Tiippana et al[19]  who conducted a meta analysis  of  22 trials using 
gabapentinoids which concluded that a single dose of gabapentin (300 -1200 
mg) given 1 to 2 hours  preoperatively significantly reduced the post operative 
pain scores and post operative opioid consumption and opioid related side 
effects. 
The patients in each group received the drugs 1 hour prior to surgery. 
This is based on the study conducted by Elinor Ben Menachem [12]  who 
reported that the time of maximal plasma concentration of pregabalin was 
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approximately 1 hour. The time of peak plasma concentration of gabapentin is 
around  2 to 3 hours( Rose et al) [11]. 
DURATION OF SURGERY 
In all the patients, standard anaesthetic technique was followed. The 
three groups were comparable in all demographic characteristics (age, sex, 
height and weight).They were also comparable in relation to ASA physical 
status and comorbid conditions. 
The mean duration of surgery in this study was 129 minutes in group P, 
130 minutes in Group G and 128 minutes in Group C. In comparison, the 
duration of surgery in the study conducted by Rajendran et al[26]  in the three 
groups were 48.17 minutes,46.7 minutes and 45.6 minutes respectively. A 
similar study was performed by Usha Bafna et al[1] in patients undergoing  
gynaecological surgeries under spinal anaesthesia  in which the duration of 
surgery was 56.8,57.2 and 57.8 minutes respectively. 
VAS Scores 
In this study, the patients were educated about the Visual Analogue 
scoring .VAS scores were measured at 0 hrs,1 hr,2hrs,3hrs,4hrs,6 hrs,9 hrs,12 
and 24 hrs after surgery. . 
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 In the immediate postoperative period (0 hr) ,VAS score showed  no  
statistically significant difference between the three groups. This may be due 
to the effect of spinal anaesthesia.  
 
The mean VAS scores during postoperative period of 1, 2, 4, 6,9, 12 and 
24 hours in group P patients were 1.86,1.93,2,2.6,3.36,3,2.83and 3.43 
respectively. In Group G patients the mean VAS scores were 1.97, 1.97, 2, 
2.76, 2.87, 2.76, 2.56 and 3.26 respectively. In Group C patients the mean 
VAS scores were 3,4.96,5.1,5.2.5.7,5.4,5.13 and 5.8 respectively. Thus the 
VAS scores were significantly less in both Groups P and G compared to 
Group C. This is similar to the results of  the study conducted by Rajendran et 
al[26] which showed significantly less VAS scores in pregabalin and 
Gabapentin group compared to placebo in the first 24 hrs post surgery. 
A study conducted by Agarwal  et al[20]   evaluated the effectiveness of a 
single dose of Pregabalin 150 mg pre operatively in patients undergoing  
laparoscopic cholecystectomy. Patients receiving pregabalin showed 
significant reduction in VAS scores in the first 24 hrs post surgery which is 
similar to the results obtained in this study. 
In a study conducted by A.Turan et al[14] in patients undergoing 
abdominal hysterectomy, gabapentin produced significantly lower VAS scores 
both during rest and movement at 1,4, 8, 12, 16, 20 and 24 hours. A meta 
analysis of 22 studies conducted by Tiipana et al[19] revealed that in patients 
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receiving  pre operative gabapentin and pregabalin there was a significant 
reduction in pain  scores during the first 24 hours  post surgery. 
SEDATION SCORES 
Postoperatively all patients were assessed for the level of sedation using 
Ramsay sedation score periodically at 0, 1, 2, 4, 6, 9,12, and 24 hours. The 
level of sedation was higher in group P and Group G patients  compared to 
Group C  upto 6 hours in the postoperative period. According to the study by 
Rose et al[11], the elimination half of gabapentin in 4.8 to 8.7 hours which 
correlates with the findings of this study. The mean elimination t1/2 of 
pregabalin is 6.3 hours and is also independent of dose and repeated drug 
administration (Ben Menachem)[12] .This was also supported by the findings in 
this study. 
In a study by C K Pandey et al[21]  in patients undergoing laproscopic 
cholecystectomy,it was found that there was higher incidence of sedation 
(33.98%) in gabapentin group of patients.Ghai et al[17] compared  effects of 
300 mg Pregabalin and 900 mg Gabapentin in 90 patients undergoing 
hysterectomy. They reported that the incidence of somnolence was 33% in 
Gabapentin group compared to control. In the study by Rajendran et al,it was 
found that both pregabalin had  slightly higher sedation scores than gabapentin 
upto 6 hours post surgery  whereas in this study the sedation scores were 
similar in pregabalin and gabapentin groups. 
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TIME OF FIRST RESCUE ANALGESIC 
Postoperatively all patients were monitored for VAS scores periodically. 
When the VAS score was 4 or greater, patients were given Tramadol 2mg/kg 
intravenously as initial dose In this study, it was found that the time interval  
for first dose of rescue analgesic with tramadol post surgery was 137.8minutes 
in  Control group, 502.3 minutes in Pregabalin group  and 382.6minutes in 
Gabapentin group. The P value was found to be 0.001, which is considered 
significant. This shows that pregabalin and gabapentin provide prolonged pain 
relief compared to control. Pregabalin gives significantly longer pain relief 
compared to gabapentin.This finding correlates with the findings in many 
other studies. 
In a study by Saraswat et al[16], the time from spinal analgesia to first 
dose of analgesic  was 8.98h in Group G whereas 14.17h in Group P, which 
was highly significant (P < 0.001).In the study conducted by Rajendran et 
al[24], the time for rescue analgesic in control, pregabalin and gabapentin 
groups were  4.93 hrs,24 and 20.76 hrs respectively. The increased time 
interval in their study could be because the rescue analgesic was given only 
when VAS scores were higher than 7 whereas in this study the rescue 
analgesic was given when VAS score was 4 and above. Moreover, the 
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duration of surgery in their study was shorter (45.6,46.7,48.17 minutes) 
compared to this study (129,130.83 and 128.33 minutes). 
 
In the study conducted by Usha Bafna et al[1] in 90 patients undergoing  
gynaecological surgeries under spinal anaesthesia, the mean duration of 
effective analgesia in pregabalin group  was 535.16 ± 32.86 min versus      
151.83 ± 16.21 min in control  group and 302.00 ± 24.26 min in gabapentin 
group .However the duration of surgery in their study were 56 minutes,59 
minutes and 57 minutes respectively. Tiipana et al ‘s meta analysis of 22 
studies[19] also gives evidence to the fact that pregabalin and gabapentin 
provide prolonged significant postoperative pain relief compared to 
placebo.This concurs with the findings of this study. 
 
DOSAGE OF TRAMADOL ADMINISTERED IN 24 HOURS POST 
SURGERY 
In this study, the mean dosage of rescue analgesic (tramadol) 
administered in 24 hours was calculated. In group C patients, average dose of 
tramadol required was 286.7 mg In group P, the dosage required was 
170mg.In group G the dosage required was 176.7mg. The P value was found 
to be 0.0001 which is highly significant.. Hence it was found that total 
tramadol consumption was significantly lower in group P and group G patients 
compared to group C.,There is no significant difference between gabapentin 
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and pregabalin group. .However in Rajendran et al’s study, the mean dosage 
of tramadol was 386.5mg in control, 90.5 mg in pregabalin group and 200.77 
in gabapentin group which showed that pregabalin was more effective than 
gabapentin in reducing opioid consumption post surgery. 
In the study conducted by Saraswat et al[16],  total dose of 
analgesics(diclofenac) in first 24h after undergoing surgery under spinal 
anaesthesia was 62.5mg in Group P(Pregabalin-300mg) and 72.5mg in Group 
G( Gabapentin 1200mg) and was not significant (P>.05). This is similar to the 
findings in this study. In a study by C.K.Pandey et al  in patients undergoing 
laparoscopic cholecystectomy the fentanyl consumption was found to be 
significantly lower in gabapentin group (221µg) than placebo group(355µg) 
with P value <0.05.There was a 35% less consumption of fentanyl in 
gabapentin group. Rorarius et al in 2004[31] conducted a study comparing pre 
operative Gabapentin 1200 mg vs oxazepam in patients undergoing 
laparoscopic hysterectomy. The post operative fentanyl consumption was 41% 
less in gabapentin group vs oxazepam. 
The findings in this study are different from the results of Ghai et al s 
study which revealed that pregabalin 300 mg, given orally 1–2 hours before 
abdominal hysterectomy, resulted in significantly reduced postoperative 
analgesic requirement compared with gabapentin 900 mg and placebo. Post 
operative diclofenac and tramadol consumption was 250 +105mg in placebo 
compared to 152+46mg  in pregabalin group and 170+54 mg in gabapentin 
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group .In a study conducted by Turan et al, gabapentin was found to reduce 
total tramadol consumption  in 24 hours by 36%  in patients undergoing 
abdominal hysterectomy. 
 
INCIDENCE OF SIDE EFFECTS 
In this study, side effects were very negligible in both Group P and 
Group G. This finding is similar to a study conducted by Dirks et al[28]. In a 
study by C K Pandey et al  in patients undergoing discectomy , it was found 
that incidence of side effects like nausea (5 vs 4) , vomiting (3vs 4) , fatigue (1 
vs 0) and dizziness (1vs 0) were found to be similar in  Gabapentin group  and  
pregabalin group. Rajendran et al ‘s study also showed no significant side 
effects in patients receiving pregabalin or gabapentin.  
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SUMMARY 
• This was a randomized, single blinded study conducted by the 
Department of Anaesthesiology ,Thanjavur Medical College in 
collaboration with the Department of Orthopaedics 
• 90 patients undergoing  lower limb surgeries under spinal anaesthesia 
were randomized and divided into 3 groups ,Group P, Group G and 
Group C 
• Group P patients received 300mg tablets of Pregabalin orally ,Group G 
received 900mg  tablets of Gabapentin and Group C patients received 
placebo tablets one hour before surgery. Standard anaesthetic technique 
was followed in all patients 
• Patients were observed at 0 hr,1,2,3,4,6,9,12 and 24 hrs post surgery 
• Post operative pain scores (VAS Score) were significantly less in 
Group P and Group G  patients compared to Group C patients  at all 
time intervals.There was no significant difference between the pain 
scores in Group P and Group G patients 
• Group P and Group G patients had higher sedation scores compared to 
Group C patients upto 6 hours post surgery.There was no significant 
difference between the sedation scores in Group P and Group G 
patients 
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• Time of first rescue analgesic was significantly prolonged in Group P 
patients (502.3 min) compared to Group G (382.6 min) and  Group C 
(137.8min) 
• The total dose of tramadol given in 24 hours as rescue analgesic was 
significantly less in Group P (170mg) and Group G ( 176.7mg) patients 
compared to Group C patients (286.7mg) 
• 4 patients in Group P had giddiness as side effect while in Group G  2 
patients had nausea and 3 had giddiness. In group C patients 5 patients 
had nausea and 3 had vomiting. 
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CONCLUSION 
 
From this study, the following were concluded 
• Preemptive  Pregabalin and Gabapentin provide good post operative 
analgesia compared to placebo in patients undergoing lower limb 
surgeries under spinal anaesthesia. 
• Pregabalin(300mg) provides prolonged pain relief compared to 
Gabapentin(900mg) in the post operative period 
• .Pregabalin and Gabapentin reduce post operative opioid requirement in 
the first 24 hours post surgery. 
• Both drugs have minimal adverse effects 
 
 
BIBLIOGRAPHY 
 
1. Bafna U, Rajarajeshwaran K, Khandelwal M, Verma AP. A comparison of 
effect of preemptive use of oral gabapentin and pregabalin for acute post-
operative pain after surgery under spinal anesthesia. Journal of 
Anaesthesiology, Clinical Pharmacology. 2014;30(3):373-377.  
2. Brennan, T. J. Pathophysiology of postoperative pain. Pain 2011; 152, S33. 
3. Imani F, Rahimzadeh P. Gabapentinoids: Gabapentin and Pregabalin for 
Postoperative Pain Management. Anesthesiology and Pain Medicine. 
2012;2(2):52-53.  
4. Emerging concepts in post-operative pain management SS Harsoor Indian J 
Anaesth. 2011 Mar-Apr; 55(2): 101–103 
5. Steeds,C.E.,The anatomy and physiology of pain.Surgery, 27 (12) (2009), 
pp. 507-511 
6. Aitkenhead AR, Rowbotham DJ, Smith G, eds (2001) Textbook of anaesthesia. 
Fourth edition. Churchill Livingstone, Edinburgh. 
7. Serpell M. (2006) Anatomy, physiology and pharmacology of pain. Surgery 24 
(10): 350-353 
8. The gate control theory of pain. British Medical Journal. 1978;2(6137):586-587 
9. Kehlet H, Dahl JB. The value of multimodal or “balanced analgesia  in 
postoperative pain treatment. Anesth Analg 1993; 77(5):1048-56 
10. Vadivelu N, Mitra S, Schermer E, Kodumudi V, Kaye AD, Urman RD. 
Preventive analgesia for postoperative pain control: a broader concept. Local 
and Regional Anesthesia. 2014;7:17-22.  
11.Rose,M.A , Kam,P.C.A (2002) 'Gabapentin:Pharmacology and its use in pain 
management', Anaesthesia, 2002(57), pp. 451-462. 
12.Ben ME. Pregabalin pharmacology and its relevance to clinical practice. 
Epilepsia 2004;45:13-8. 
13.Fink R. Pain assessment: the cornerstone to optimal pain 
management. Proceedings (Baylor University Medical Center). 
2000;13(3):236-239. 
14.Turan A, Karamanlioglu B, Memis D, Hamamcioglu MK, Tükenmez B, , et al. 
     Analgesic effects of Gabapentin after spinal surgery. Anaesthesiology 
2004;100:935-8. 
15. Hill CM, Balkenohl M, Thomas DW, Walker R, Mathe H,Murray G. 
Pregabalin in   patients with postoperative dental pain.Eur J Pain 2001;5:119-
24. 
16. Saraswat V, Arora V. Preemptive gabapentin vs pregabalin for acute 
postoperative pain after surgery under spinal anaesthesia. Indian J Anaesth 
2008;52:829-34. 
17.Ghai A, Gupta M, Hooda S, Singla D, Wadhera R. A randomized controlled 
trial to compare pregabalin with gabapentin for postoperative pain in abdominal 
hysterectomy. Saudi J Anaesth 2011;5:252-7. 
 18.Montaser A. Mohamed M.D., Ahmed H. Othman M.D., Ahmad M. Abd El-
Rahman M.D Analgesic efficacy and safety of peri-operative pregabalin 
following radical cystectomy:A dose grading study.Egypt J Anaesth 
(2016),   http://dx.doi.org/10.1016/ j.egja.2016.10.003 
19. Tiippana EM, Hamunen K, Kontinen VK, Kalso E. Do surgical patients 
benefit from preoperative gabapentin/pregabalin? A systematic review of 
efficacy and safety.  
Anaesth Analg 2007;104:1545-56. 
20. Agarwal A, Gautam S, Gupta D, Agarwal S, Singh PK, Singh U. Evaluation of 
a single preoperative dose of Pregabalin for attenuation of post operative pain 
after laproscopic cholecystectomy. Br J Anaesth 2008;101:700 
21. Pandey CK, Priye S, Singh S, Singh U, Singh RB, Singh PK. Preemptive use 
of gabapentin significantly decreases postoperative pain and rescue analgesic 
requirements in laparoscopic cholecystectomy. Can J Anaesth 2004;51: 358-
63. 
22. Fassoulaki A, Patris K, Sarantopoulos C, Hogan Q. The analgesic effect of 
Gabapentin and mexiletine after breast surgery for cancer. Anesth Analg 
2002;95:985-91 
23. Al-Mujadi H, A-Rfai AR, Katzarov MG, Dehrab NA, Batra YK, Al-Qattan 
AR. Preemptive Gabapentin reduces postoperative pain and opioid demand 
following thyroid surgery. Can J Anesth 2006;53:268-73. 
24. Jokela R, Ahonen J, Taligren M, Haanpaa M, Kortilla K. Pretreatment with 
pregabalin 75 or 150 mg with ibuprofen to control pain after day care 
gynaecological laproscopic surgery. Br J Anaesth 2008;100:834-40. 
25. Panah Khahi M. Yaghooti A. A. et el. Effect of pre-emptive gabapentin on 
post-operative pain following lower extremity orthopedic surgery under spinal 
Anesthesia. Singapore Med J 2011; 51 (12) : 879-882. 
26. Rajendran I, Basavareddy A, Meher BR, Srinivasan S. Prospective, 
randomised, double blinded controlled trial of gabapentin and pregabalin as 
pre emptive analgesia in patients undergoing lower abdominal and limb 
surgery under spinal anaesthesia. Indian J Pain 2014;28:155-9. 
27. New modalities of pain treatment after outpatient orthopaedic surgery M. 
Beaussier∗, D. Sciard , A. Orthopaedics & Traumatology: Surgery & 
Research 102 (2016) S121–S124 
28. Dirks, Jesper et el. A randomized study of effects of single dose Gabapentin 
versus Placebo on post-operative pain and Morphine consumption after 
Mastectomy. Anesthesiology Sep 2002; 97 (3) : 560 – 564. 
29. Paech MJ, Goy R, Chua S, Scott K, Christmas T, Doherty DA. A randomized, 
placebo-controlled trial of preoperative oral pregabalin for postoperative pain 
relief after minor gynecological surgery. Anesth Analg 2007; 105: 1449–53 
30. Schmidt,P.C,* Ruchelli,G , Mackey,S (2013) 'Perioperative Gabapentinoids: 
Choice of Agent, Dose, Timing, and Effects on Chronic Post surgical 
Pain',  Anaesthesiology, (119), pp. 1215-21. 
31. Rorarius M.G.F., Mennander S., et el. Gabapentin for the prevention of post-
operative pain after vaginal hysterectomy. Pain 2004; 110 : 175-81 
32. Khan ZH, Rahimi M, Makarem J, Khan RH: Optimal dose of pre-
incision/post-incision gabapentin for pain relief following lumbar laminectomy: 
A randomized study. Acta Anaesthesiol Scand 2011; 55:306–12 
33. Turan, A ;Memiş, D. (2004). The Analgesic Effects of Gabapentin in 
Monitored Anesthesia Care for Ear-Nose-Throat Surgery. Anesthesia and 
analgesia. 99. 375-8 
34. Verma A, Arya S, Sahu S, Lata I, Pandey H D, Singh H. To Evaluate the Role 
of Gabapentin as Preemptive Analgesic in Patients Undergoing Total 
Abdominal Hysterectomy in Epidural Anaesthesia. Indian J Anaesth  2008 
;52:428 
PROFORMA 
NAME:                                                       AGE:                      SEX:                  IP NO: 
HT:                                   WT:          
DIAGNOSIS:                                                                       
SURGERY:                                                                          
ASA Physical Status: 
Co-Morbidity:                                                                                                      
 
SUB ARACHNOID BLOCK 
Local anaesthetic given:                                                Dosage of local anaesthetic: 
Additives:                                                                          
Pre- OP:                 
     PR:                                BP:                                        SPO2: 
 
DURATION OF SURGERY : 
 
POST-OP PAIN SCORE (VAS SCORE)  
TIME 0 
HOURS  
3 
HOURS 
2 
HOURS 
3 
HOURS 
4 
HOURS 
6 
HOURS 
9 
HOURS 
12 
HOURS 
24 
HOURS 
SCORE          
 
VAS SCORE 
 
0 1 2 3          4            5           6            7            8              9             10 
 
   MILD                        MODERATE       SEVERE 
 
POST OPERATIVE SEDATION SCORE (RAMSAY SEDATION SCORE) 
Time 0 Hours 
1 
hours 
2 
hours 
3 
Hours 
4 
Hours 
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RAMSAY SEDATION SCALE 
AWAKE LEVELS 
1 = ANXIOUS, AGITATED;  
2 = ORIENTED, CO OPERATIVE, TRANQUIL;  
3 = RESPONDS TO COMMAND; 
 
ASLEEP LEVELS  
RESPONSE TO A LIGHT GLABELLAR TAP OR LOUD AUDITORY 
STIMULUS; 
4 = BRISK RESPONSE; 5 = SLUGGISH RESPONSE; AND  
6 = NO RESPONSE) 
 
TIME FOR FIRST RESCUE ANALGESIC: 
RESCUE ANALGESICS IN FIRST 24 HRS 
 
 
COMPLICATIONS: 
 
TIME     
ANALGESIC     
SNo Group Age Sex HT Wt ASA Diagnosis Surgery Duration Comorbid VAS VAS VAS VAS
0 1 2
1 P 50 M 160 64 1 BB# RT LEG DFLCP 120 NIL 1 1 1 1
2 P 18 M 158 45 1 # RT FEMUR ORIF NAIL 135 NIL 1 2 2 2
3 P 45 F 152 60 1 BB # LT LEG ORIF NAIL 130 NIL 2 2 2 2
4 P 22 M 162 48 1  BB# RT LEG ILLIZAROV 145 NIL 1 2 2 2
5 P 23 M 160 52 1 INFECTED IMPLANT LT LEG IMPLANT EXIT 90 NIL 1 1 1 2
6 P 48 F 150 55 2 BB # RLT LEG ORIF NAIL 145 DM,HT 1 1 2 3
7 P 20 M 165 65 1 BB# RT LEG ORIF  PLATING 140 NIL 1 2 2 2
8 P 46 M 166 60 2 INFECTED IMPLANT LT FEMUR IMPLANT EXIT 95 NIL 1 2 2 2
9 P 25 M 165 60 2 # LT FEMUR DHS 155 NIL 1 2 2 2
10 P 24 M 168 70 1 # RT FEMUR ORIF 150 NIL 1 2 2 2
11 P 47 M 156 50 1 BB# RT LEG ILLIZAROV CORTICOTOMY RING ADJ 100 NIL 2 2 2 2
12 P 55 M 164 65 2 # RT TIBIA ORIF NAIL 155 SMOKER 1 2 2 2
13 P 60 M 162 58 2 RT FEMUR # CLOSED ORIF PLATING 140 SMOKER 1 2 2 2
14 P 55 M 165 54 2 # LT TIBIA ORIF PLATING 160 SMOKER 2 2 2 2
15 P 57 M 168 65 2 BB # RT LEG ORIF PLATING 140 SMOKER 2 2 2 2
16 P 50 M 167 64 1 ACL TEAR LT ARTHROSCOPY 115 NIL 2 2 2 2
17 P 55 M 166 55 2 BB # RT LEG CORTICOTOMY RING ADJ 100 DM 2 2 2 2
18 P 35 M 158 50 1 PATELLAR # TBW 120 NIL 2 2 2 2
19 P 36 M 162 60 1 LT FEMUR # LT INTERTROCHANTERIC DHS 125 NIL 2 2 2 2
20 P 49 M 156 60 1 TRIMALLEOLAR # ANKLE ORIF PLATING 150 NIL 2 2 2 2
21 P 45 M 155 45 1 BB # RT LEG ORIF NAIL 110 NIL 2 2 2 2
22 P 46 M 160 66 2 NONUNION # RT TIBIA ILIZAROV 140 NIL 2 2 2 2
23 P 59 M 161 60 2 # LT TIBIA ORIF NAIL 115 HT 2 2 2 2
24 P 58 M 164 50 2 BB # LT LEG ORIF NAIL 130 DM 2 2 2 2
25 P 45 M 164 56 1 BB # RT LEG ORIF NAIL 105 NIL 2 2 2 2
26 P 34 M 165 60 1 # FEMUR LT ORIF NAIL 160 NIL 1 1 2 2
27 P 60 M 158 60 2 BB # RT LEG ON ILLIZAROV REALIGNMENT 95 SMOKER 1 2 2 2
28 P 19 M 163 65 2 BB # RT LEG ORIF NAIL 135 NIL 2 2 2 2
29 P 59 M 165 62 2 BB # RT LEG ORIF NAIL 115 SMOKER 2 2 2 2
30 P 24 M 166 64 1 OSTEOMYELITIS RT TIBIA ILLIZAROV FIXATION 155 NIL 1 2 2 2
SNo Group Age Sex HT Wt ASA Diagnosis Surgery Duration Comorbid VAS VAS VAS VAS
31 G 34 M 165 62 1 # RT TIBIA ILLIZAROV 150 NIL 1 1 1 2
32 G 55 M 158 64 2 BB # RT LEG ORIF NAIL 130 NIL 2 2 2 2
33 G 19 M 154 52 1 # LT FEMUR ORIF NAIL 160 NIL 1 2 2 2
34 G 52 M 161 56 2 # LT FEMUR ORIF NAIL 125 HT 2 2 2 2
35 G 30 M 162 63 1 # LT FEMUR ORIF PLATING 155 NIL 2 2 2 2
36 G 48 M 165 68 2 BB # RT LEG ORIF NAIL 135 NIL 2 2 2 2
37 G 22 M 155 62 1 # RT TIBIA ORIF NAIL 100 NIL 2 2 2 2
38 G 30 M 160 51 2 BB # LT LEG ILLIZAROV REMOVAL AND CAPSULOTOMY 105 SMOKER 2 2 2 2
39 G 24 M 166 58 1 # LT FEMUR ORIF NAIL 140 NIL 2 2 2 2
40 G 37 M 160 70 2 CLOSED # LT FIBULA ARTHROSCOPY 150 DM,HT 2 2 2 2
41 G 19 M 155 55 1 BB# LT LEG ILLIZAROV 165 NIL 2 2 2 2
42 G 46 M 160 54 2  BB# RT LEG ON ILLIZAROV ILLIZAROV RING ADJUSTMENT 90 SMOKER 2 2 2 2
43 G 55 M 156 60 1 ANKLE DISLOCATION RT ANKLE ARTHRODESIS 150 NIL 2 2 2 2
44 G 32 M 163 68 2 RT FEMUR NAIL IN SITU IMPLANT EXIT 105 SMOKER 2 2 2 2
45 G 31 M 157 59 1 RT FEMUR # CLOSED ORIF NAIL 120 NIL 2 2 2 2
46 G 57 M 166 70 2 CLOSED # RT INTERTROCHANTERIC FEMURNAILING 130 SMOKER 2 2 2 2
47 G 34 M 158 52 1 # RT TIBIA LAT CONDYLE ORIF PLATING 180 NIL 2 2 2 2
48 G 25 M 158 50 1 # LT FEMUR ORIF NAIL 135 NIL 2 2 2 2
49 G 18 M 156 49 1 BB # LT LEG ORIF NAIL 110 NIL 2 2 2 2
50 G 58 M 165 58 2 # RT FEMUR LRS FIXATION 125 SMOKER 2 2 2 2
51 G 55 M 160 64 2 INFECTED IMPLANT RT LEG IMPLANT EXIT 100 SMOKER 2 2 2 2
52 G 50 M 156 48 2 CLOSED # RT FEMUR LRS FIXATION 150 SMOKER 2 2 2 2
53 G 45 M 166 65 2 CLOSED # RT FEMUR ORIF NAIL 145 SMOKER 2 2 2 2
54 G 51 M 168 68 2 MALUNITED # RT TIBIA IMPLANT REMOVAL AND LRS FIXATION 160 DM,HT 2 2 2 2
55 G 30 F 156 50 1 # RT FEMUR SHAFT ORIF NAIL 120 NIL 2 2 2 2
56 G 52 M 167 60 2 # BB RT LEG ORIF NAIL 135 SMOKER 2 2 2 2
57 G 44 M 163 60 1 # LT TIBIA PLATEAU ORIF NAIL 125 NIL 2 2 2 2
58 G 18 M 160 48 1 # LT FEMUR SHAFT ORIF PLATING 120 NIL 2 2 2 2
59 G 27 M 165 63 1 # RT FEMUR SHAFT ORIF NAIL 155 NIL 2 2 2 2
SNo Group Age Sex HT Wt ASA Diagnosis Surgery Duration Comorbid VAS VAS VAS VAS
60 G 51 M 162 60 2 # RT FEMUR INTERTROCHANTERIC PFN 145 DM,HT 2 2 2 2
61 C 45 M 158 58 1 INFECTED IMPLANT LT LEG IMPLANT EXIT 100 NIL 2 3 2 4
62 C 33 M 160 60 2 SUBTALAR ARTHRITIS RT ANKLE ARTHRODESIS 120 SMOKER 2 2 2 4
63 C 60 M 162 65 2 # RT TIBIA ORIF NAIL 135 SMOKER 2 2 2 4
64 C 56 F 150 48 2 # RT FEMUR SUBTROCHANTERIC ORIF PLATING 140 DM,HT 2 3 4 2
65 C 28 M 163 60 1 BB # RT LEG ORIF NAIL 110 NIL 2 2 2 4
66 C 55 M 165 65 2 BB # LT LEG ORIF NAIL 125 HT 2 2 4 2
67 C 29 M 164 52 1 CLOSED # LT FEMUR IT DHS 145 NIL 3 4 2 2
68 C 52 M 169 64 2 BB# RT LEG EXTERNAL FIXATOR 125 HT 2 3 4 2
69 C 36 M 170 70 1 BB # RT LEG ORIF NAIL 105 NIL 2 2 3 4
70 C 46 M 168 66 2 ACL TEAR RT ARTHROSCOPY 125 HT 2 2 4 3
71 C 24 M 172 64 1 SHAFT OF FEMUR# RT ORIF NAIL 135 NIL 2 4 3 2
72 C 60 M 160 60 2 # RT FEMUR INTERTROCHANTERIC PFN 150 SMOKER 2 4 2 2
73 C 58 M 165 65 2 CLOSED # NECKOF FEMUR HEMIARTHROPLASTY 135 SMOKER 2 2 4 2
74 C 23 M 158 55 1 # LT TIBIA PLATEAU ORIF NAIL 120 NIL 2 2 2 4
75 C 56 M 163 58 2 INTERTROCHANTERIC # FEMUR RT PFN 150 HT 2 4 2 2
76 C 40 M 158 56 2 # RT FEMUR SHAFT ORIF NAIL 115 HT 2 3 4 2
77 C 40 M 162 57 1 # RT TIBIAL PLATEAU ORIF PLATING 105 NIL 2 2 3 4
78 C 37 M 165 60 2 # RT FEMUR SUBTROCHANTERIC DHS 140 DM,HT 2 4 2 2
79 C 25 M 166 64 1 # SHAFT OF FEMUR RT ORIF NAIL 130 NIL 2 3 4 2
80 C 30 M 165 70 1 # RT FEMUR SHAFT ORIF NAIL 120 NIL 2 3 5 3
81 C 27 M 163 72 1 BB # RT LEG ORIF NAIL 90 NIL 2 3 3 5
82 C 50 M 159 62 2 BB # RT LEG ORIF NAIL 115 SMOKER 2 3 3 4
83 C 27 M 168 64 1 # BB RT LEG ORIF NAIL 140 NIL 2 3 5 2
84 C 60 F 155 50 2 # LT TIBIA PLATEAU ORIF PLATING 120 DM 2 3 3 4
85 C 27 M 167 60 2 # BB RT LEG ORIF NAIL 105 SMOKER 2 2 3 5
86 C 60 M 165 55 2 # BB LT LEG ORIF NAIL 140 SMOKER 3 4 2 3
87 C 17 M 160 54 1 TIBIAL EPIPHYSEAL INJURY ORIF PLATING 125 NIL 2 3 3 5
88 C 17 M 162 50 1 # RT FEMUR SPRACONDYLAR ORIF PLATING 130 NIL 2 3 3 4
89 C 60 M 165 60 2 BB # RT LEG ORIF PLATING 170 SMOKER 3 5 3 2
90 C 27 M 172 72 1 BB # RT LEG ORIF NAIL 155 NIL 3 5 3 3
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NAUSEA VOMITING GIDDINESS
3 4 6 9 12 24 0 1 2 3 4 6 9 12 24
2 2 5 5 6 2 2 2 2 2 2 1 2 1 480 200 A A A
2 4 3 4 3 2 2 2 2 2 1 2 1 2 360 200 A A A
2 5 3 4 4 2 2 2 2 2 1 2 1 2 300 200 A A A
3 4 2 2 4 2 2 2 2 2 1 2 2 1 360 200 A A A
3 4 3 3 4 2 2 2 2 2 1 2 2 2 360 100 A A A
3 4 4 3 4 2 2 2 2 2 1 1 2 1 330 200 A A P
4 2 3 4 2 2 2 2 2 1 2 2 1 2 240 200 A A A
3 4 3 3 5 2 2 2 2 2 1 2 2 1 350 200 A A A
4 3 4 3 4 2 2 2 2 2 1 2 2 1 260 200 A A A
2 4 3 4 3 2 2 2 2 2 1 2 1 2 370 200 P A A
3 3 4 3 4 2 2 2 2 2 2 1 2 1 540 100 A A A
3 4 2 3 4 2 2 2 2 2 1 2 2 1 380 200 A A A
2 3 4 2 2 2 2 2 2 2 2 1 2 2 550 100 A A A
4 2 2 4 2 2 2 2 1 2 2 2 1 2 250 200 A A A
3 5 2 2 4 2 2 2 2 2 1 2 2 1 360 200 A A A
3 4 2 2 2 2 2 2 2 2 1 2 2 2 340 100 A A A
2 2 4 2 4 2 2 2 2 2 2 1 2 1 530 200 A A A
2 5 2 2 4 2 2 2 2 2 1 2 2 1 370 200 A A A
4 2 2 3 4 2 2 2 2 1 2 2 2 1 220 200 A A A
2 2 4 2 2 2 2 2 2 2 2 1 2 2 530 100 A A A
2 4 2 2 4 2 2 2 2 2 1 2 2 1 350 200 A A A
4 2 2 2 4 2 2 2 2 1 2 2 2 2 240 100 A A A
2 5 2 4 2 2 2 2 2 2 1 2 1 2 350 200 A A A
2 4 3 3 4 2 2 2 2 2 1 2 2 1 360 200 A A A
2 2 4 2 2 2 2 2 2 2 2 1 2 2 550 100 A A A
2 4 2 2 4 2 2 2 2 2 1 2 2 1 370 200 A A A
2 2 4 2 2 2 2 2 2 2 2 1 2 2 540 100 A A A
2 4 2 2 4 2 2 2 2 2 1 2 2 1 360 200 A A A
2 2 4 2 4 2 2 2 2 2 2 1 2 2 520 100 A A A
2 4 2 4 2 2 2 2 2 2 1 2 1 2 350 200 A A A
SNo
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
VAS 
score
VAS VAS VAS VAS RAMSAY
RAM
SAY
RAM
SAY
RAM
SAY
RAM
SAY
RAM
SAY
RAM
SAY
RAM
SAY
RAM
SAY T1
TRAMADOL 
24hrs
NAUSEA VOMITING GIDDINESS
3 3 4 3 4 3 3 3 2 2 2 2 2 2 510 100 A A A
2 4 2 2 4 3 3 2 2 2 1 2 2 1 370 200 A A P
2 4 2 2 4 3 2 2 1 2 2 1 2 2 360 200 P A P
2 2 4 2 2 3 3 2 2 2 2 1 2 2 540 100 A A P
4 2 2 2 4 3 2 2 2 2 1 2 2 2 350 100 A A A
2 3 5 2 4 3 2 2 2 2 2 1 2 1 500 200 A A A
2 4 2 2 4 3 3 2 2 2 1 2 2 1 360 200 A A P
2 2 4 2 2 3 3 2 2 2 2 1 2 2 550 100 A A A
2 4 2 4 2 3 2 2 2 2 1 2 1 2 350 200 A A P
4 2 2 2 4 3 2 2 2 1 2 2 2 1 250 200 A A P
5 3 2 4 2 3 2 2 2 1 2 2 1 2 240 200 A A A
2 2 4 2 2 3 3 3 2 2 2 1 2 2 530 100 P A P
2 4 2 4 2 3 2 2 2 2 1 2 1 2 350 200 A A A
2 2 4 2 4 3 3 2 2 2 2 1 2 1 540 200 A A A
2 4 2 2 4 3 2 2 2 2 1 2 2 1 380 200 A A A
2 4 2 2 2 3 2 2 2 2 1 2 2 1 300 200 A A A
4 2 2 4 4 2 2 2 2 1 2 2 1 1 240 200 P A A
2 4 2 2 2 3 3 2 2 2 1 2 2 2 350 100 A A A
2 2 4 2 4 3 3 2 2 2 2 1 2 1 560 200 A A A
2 4 2 2 4 3 3 2 2 2 1 2 2 1 320 200 A A A
2 2 4 2 2 3 3 3 2 2 2 1 2 2 570 100 A A P
4 3 2 4 2 2 2 2 2 1 2 2 1 2 250 200 A A A
4 2 2 4 4 3 2 2 2 1 2 2 1 1 240 200 A A A
5 2 2 2 4 2 2 2 2 1 2 2 2 1 230 200 A A P
3 4 2 2 4 3 2 2 2 2 1 2 2 1 360 200 P A P
2 2 4 2 4 3 3 2 2 2 2 1 2 1 500 200 A A A
2 4 2 2 4 3 2 2 2 2 1 2 2 1 400 200 A A A
2 2 4 2 2 2 2 2 2 2 2 1 2 2 520 100 A A A
4 2 2 4 4 2 2 2 2 1 2 2 4 4 240 200 A A P
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5 2 2 4 4 2 2 2 2 1 2 2 1 1 220 300 A A A
2 2 4 2 5 2 2 1 2 2 2 1 2 1 180 300 P A A
2 2 5 3 5 2 2 2 1 2 2 1 2 1 160 300 A A A
2 2 4 2 5 2 2 2 1 2 2 1 2 1 170 300 P A A
2 2 4 2 5 2 1 2 2 2 2 1 2 1 110 300 A A A
2 2 4 2 5 2 2 2 1 2 2 1 2 1 190 300 A A A
2 2 4 2 5 2 2 1 2 2 2 1 2 1 120 300 A A A
3 3 4 3 5 2 1 2 2 2 2 1 2 1 60 300 P A A
2 3 2 4 5 2 2 1 2 2 2 2 1 1 130 300 A A A
2 2 2 4 5 2 2 2 1 2 2 2 1 1 160 300 A A A
3 3 4 2 5 2 2 1 2 2 2 1 2 1 125 300 P A A
2 2 4 2 3 2 1 2 2 2 2 1 2 2 100 200 A P A
2 4 2 2 5 2 1 2 2 2 1 2 2 1 90 300 A A A
2 2 2 4 5 2 2 1 2 2 2 2 1 1 140 300 A A A
2 2 2 2 5 2 2 2 1 2 2 2 2 1 180 200 A P A
2 2 4 3 5 2 1 2 2 2 2 1 2 1 75 300 A A A
2 2 2 4 6 2 2 1 2 2 2 2 1 1 140 300 A A A
2 2 2 4 3 2 2 2 1 2 2 2 1 2 190 200 A A A
2 2 4 2 5 2 1 2 2 2 2 1 2 1 70 300 P A A
2 2 2 4 5 2 2 1 2 2 2 2 1 1 135 300 A A A
2 2 5 3 5 2 2 1 2 2 2 1 2 1 120 300 A P A
2 2 2 4 5 2 2 2 1 2 2 2 1 1 200 300 A A A
2 2 2 5 4 2 2 2 1 2 2 2 1 1 190 300 A A A
2 3 4 3 5 2 2 1 2 2 2 1 2 1 130 300 A A A
2 2 3 5 5 2 2 2 1 2 2 2 1 1 180 300 A A A
3 2 2 4 4 2 2 2 1 2 2 2 1 1 180 300 A A A
2 3 5 3 4 2 1 2 2 2 2 1 2 1 80 300 A A A
3 3 5 3 5 2 2 2 1 2 2 1 2 1 205 200 A A A
2 3 3 5 5 2 2 2 1 2 2 2 1 1 170 300 A A A
2 3 5 3 6 2 1 2 2 2 2 1 2 1 80 300 A A A
3 3 5 3 4 2 1 2 2 2 2 1 2 1 75 300 A A A
